Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04899778 · ClinicalTrials.gov registry record · Phase 4
Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes
A Phase 4 study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 73
- Enrollment target
NCT04899778 is a Phase 4 study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 73 participants.
The verdict
NCT04899778, a Phase 4 study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 73 participants
- Enrollment target
Study Summary
The purpose of this research study is to examine the impact of one type of commonly used birth control pill on blood levels of relaxin and measure changes in knee movement to determine whether there are changes in joint instability (indicating the knee is less stable) that may predispose female athletes to injury. Women not on hormonal birth control will also be enrolled to analyze differences between athletes on and not on birth control and to evaluate typical relaxin levels and knee laxity when birth control pills are not used.
Interventions
- DRUG Oral Contraceptive Pill, norethindrn a-e estradiol-iron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2021-09-29 |
| Est. Completion | 2024-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04899778
The ClinicalTrials.gov registry entry for NCT04899778 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral Contraceptive Pill, norethindrn a-e estradiol-iron is the first listed.
NCT04899778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04899778 about?
NCT04899778 is a clinical study titled "Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes". The purpose of this research study is to examine the impact of one type of commonly used birth control pill on blood levels of relaxin and measure changes in knee movement to determine whether there are changes in joint instability (indicating the knee is less stable) that may predispose female athl...
What is the current status of trial NCT04899778?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 73 participants. The study started on 2021-09-29. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT04899778?
The interventions under investigation include: Oral Contraceptive Pill, norethindrn a-e estradiol-iron (DRUG).
Who is sponsoring clinical trial NCT04899778?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.